Zydus Cadila gets tentative approval from USFDA for Adapalene and Benzoyl Peroxide Gel

08 Oct 2021 Evaluate

Zydus Cadila has received tentative approval from the USFDA to market Adapalene and Benzoyl Peroxide Gel 0.3%/2.5%. (USRLD: Epiduo Forte). Adapalene and Benzoyl Peroxide combination is used to treat acne. It works by killing the bacteria that cause acne and by keeping the skin pores clean. The drug will be manufactured at the group’s Topical plant at Ahmedabad.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

884.00 -16.25 (-1.81%)
14-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1700.55
Dr. Reddys Lab 1186.45
Cipla 1434.60
Zydus Lifesciences 884.00
Lupin 2195.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×